The Cost-Effectiveness of Ustekinumab in Moderate to Severely Active Crohn’s Disease in Sweden
Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.1435
https://www.valueinhealthjournal.com/article/S1098-3015(17)31769-2/fulltext
Title :
The Cost-Effectiveness of Ustekinumab in Moderate to Severely Active Crohn’s Disease in Sweden
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)31769-2&doi=10.1016/j.jval.2017.08.1435
First page :
A634
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1277